Filing Details
Genprex, Inc. (NASDAQ:GNPX) filed a Form 8-K with the Securities and Exchange Commission on August 18, 2026, disclosing a material event.
8k filedNASDAQ:GNPX
Genprex, Inc. (GNPX) Reports Material Event to SEC
Genprex, Inc. (NASDAQ:GNPX) filed a Form 8-K with the Securities and Exchange Commission on August 18, 2026, disclosing a material event.
At publication ·
What changed
Genprex, Inc. (NASDAQ:GNPX) · 8k filed
- Form
- 8-K
At a glance
Key takeaways
- Genprex, Inc. (NASDAQ:GNPX) filed a Form 8-K with the SEC on August 18, 2026, disclosing a material event that shareholders should be aware of, though the specific nature of the event is not detailed in this filing summary.
- The company's stock trades at $3.95 with a market capitalization of $5.3 million as of the filing date.
- Form 8-K filings are used to report material events such as leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance that occur between regular quarterly or annual reports.
Market Context
Genprex, Inc.'s stock currently trades at $3.95 with a market capitalization of $5.3M. The Healthcare company's stock moved following the disclosure.
8-K filings report material events that shareholders should know about between regular quarterly or annual reports. These can include leadership changes, material agreements, acquisitions, asset sales, or changes to financial guidance. The specific nature of the event determines its significance for Genprex, Inc.'s stock.
All SEC filings for Genprex, Inc. are publicly available through the SEC's EDGAR database. Investors can set up alerts for new filings to stay current on material developments.
Related Tools: View GNPX Stock Page
Frequently Asked Questions
Where can I read GNPX's SEC filings?
Browse all filings on our GNPX SEC filings page.
What types of SEC filings does Genprex, Inc. file?
Public companies like Genprex, Inc. file annual reports (10-K), quarterly reports (10-Q), material events (8-K), and insider transactions (Form 4) with the SEC.